Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 35

1.

Determining public health priorities for an ageing population: the value of a disability survey.

Jitapunkul S, Kunanusont C, Phoolcharoen W, Suriyawongpaisal P, Ebrahim S.

Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):929-36.

PMID:
15115112
2.

Can we reduce disease burden from osteoarthritis?

Segal L, Day SE, Chapman AB, Osborne RH.

Med J Aust. 2004 Mar 1;180(5 Suppl):S11-7.

PMID:
14984357
3.

The burden of musculoskeletal conditions at the start of the new millennium.

WHO Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium.

World Health Organ Tech Rep Ser. 2003;919:i-x, 1-218, back cover.

PMID:
14679827
4.

Treatment of established osteoporosis: a systematic review and cost-utility analysis.

Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M.

Health Technol Assess. 2002;6(29):1-146. Review. No abstract available.

5.

Rheumatic disorders in Sub-saharan Africa.

McGill PE, Oyoo GO.

East Afr Med J. 2002 Apr;79(4):214-6. Review.

PMID:
12625680
6.

Treatment- and cost-effectiveness of early intervention for acute low-back pain patients: a one-year prospective study.

Gatchel RJ, Polatin PB, Noe C, Gardea M, Pulliam C, Thompson J.

J Occup Rehabil. 2003 Mar;13(1):1-9.

PMID:
12611026
7.

The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden.

Willis MS.

Int J Technol Assess Health Care. 2002 Fall;18(4):791-807.

PMID:
12602080
8.
10.

Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.

Van Tubergen A, Boonen A, Landewé R, Rutten-Van Mölken M, Van Der Heijde D, Hidding A, Van Der Linden S.

Arthritis Rheum. 2002 Oct 15;47(5):459-67.

11.

Massage for low-back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group.

Furlan AD, Brosseau L, Imamura M, Irvin E.

Spine (Phila Pa 1976). 2002 Sep 1;27(17):1896-910. Review.

PMID:
12221356
13.

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.

Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P; Canadian Knee OA Study Group.

Osteoarthritis Cartilage. 2002 Jul;10(7):518-27.

14.

Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology.

Gabriel SE, Tugwell P, Drummond M.

Ann Rheum Dis. 2002 Apr;61(4):370-3.

15.

Review of the function of a telephone helpline in the treatment of outpatients with rheumatoid arthritis.

Hughes RA, Carr ME, Huggett A, Thwaites CE.

Ann Rheum Dis. 2002 Apr;61(4):341-5.

16.

Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.

Armstrong K, Chen TM, Albert D, Randall TC, Schwartz JS.

Obstet Gynecol. 2001 Dec;98(6):996-1003.

PMID:
11755544
17.

A clinical and economic review of disease-modifying antirheumatic drugs.

Gabriel SE, Coyle D, Moreland LW.

Pharmacoeconomics. 2001;19(7):715-28. Review.

PMID:
11548909
18.
19.

Economic evaluation of aquatic exercise for persons with osteoarthritis.

Patrick DL, Ramsey SD, Spencer AC, Kinne S, Belza B, Topolski TD.

Med Care. 2001 May;39(5):413-24.

PMID:
11317090
20.

The economic burden of physical inactivity in Canada.

Katzmarzyk PT, Gledhill N, Shephard RJ.

CMAJ. 2000 Nov 28;163(11):1435-40.

Supplemental Content

Support Center